Tilmicosin

Description

1. Product Overview

Tilmicosin is a semi-synthetic macrolide antibiotic widely used in veterinary medicine for the treatment and control of respiratory infections in livestock. It is primarily utilized in poultry, swine, and cattle production systems to combat bacterial pathogens and improve herd health outcomes. The key value proposition lies in its long-acting efficacy, strong tissue penetration, and targeted activity against respiratory pathogens, resulting in improved productivity and reduced mortality rates. Strategically, tilmicosin plays a critical role in modern animal health management, supporting efficient protein production and biosecurity in large-scale agricultural operations.

2. Key Specifications & Technical Characteristics

• Chemical Composition:
  • Active ingredient: Tilmicosin (macrolide antibiotic)
  • Molecular formula: C₄₆H₈₀N₂O₁₃ (base compound)
  • May be supplied as tilmicosin phosphate in formulated products
• Purity Level / Grade:
  • Veterinary pharmaceutical grade
  • Typical assay: ≥95% (depending on formulation and manufacturer)
  • Complies with relevant pharmacopeial or manufacturer specifications
• Physical Characteristics:
  • Form: Powder or liquid concentrate (formulation-dependent)
  • Color: White to off-white (powder) or light yellow solution
  • Odor: Mild characteristic
  • Solubility: Soluble in organic solvents; limited solubility in water (formulation-dependent)
• Packaging Options:
  • Fiber drums or cartons for powder (typically 20–25 kg)
  • HDPE drums or jerrycans for liquid formulations
  • Bulk packaging available upon request
• Shelf Life:
  • Typically 24 months under recommended storage conditions
  • Store in cool, dry, and well-sealed containers away from light

3. Core Industrial Applications

Primary Industries:

• Veterinary pharmaceuticals
• Animal health and livestock production
• Feed additive and medicated premix manufacturing
• Poultry and aquaculture operations

Operational Use Cases:

• Treatment and prevention of bovine respiratory disease (BRD)
• Control of swine respiratory infections
• Poultry disease management through medicated feed or water systems
• Formulation of veterinary injectable or oral dosage products

Performance & Cost Advantages:
Tilmicosin offers extended duration of action and strong accumulation in lung tissues, reducing dosing frequency and improving treatment efficiency. Its targeted antibacterial spectrum enhances therapeutic outcomes while minimizing unnecessary antibiotic use. For livestock producers, this translates into improved feed conversion ratios, lower mortality, and optimized production economics.

4. Competitive Advantages

• Quality Consistency: Manufactured under controlled pharmaceutical-grade standards with batch-level validation
• Supply Reliability: Stable global supply chain with scalable production capacity
• Logistics Capability: Compliant handling and distribution aligned with veterinary pharmaceutical regulations
• Price Competitiveness: Cost-effective solution compared to alternative macrolides in large-scale livestock applications
• Sustainability Benefits: Supports efficient livestock production and reduces economic losses due to disease
• Technical Documentation: Full regulatory documentation including COA, SDS, and quality certifications available

Positioned as a strategic input in animal health management, tilmicosin enables producers and pharmaceutical formulators to enhance disease control, optimize productivity, and maintain consistent livestock performance.

5. Commercial & Supply Information

• Minimum Order Quantity (MOQ): BULK 20MT
• Loading Capacity (MT per container): Approximately 10–20 MT per 20’ container (depending on packaging and regulatory classification)